Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    15801322 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed ICATA Asthma Mechanistic Study
Condition: Asthma
Intervention: Biological: Omalizumab
2 Completed
Has Results
Inner-City Anti-IgE Therapy for Asthma
Condition: Asthma
Interventions: Biological: omalizumab;   Biological: omalizumab placebo

Study has passed its completion date and status has not been verified in more than two years.